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Previously we established Zygote Electroporation of Nucleases (ZEN) technology as an efficient and high-throughput way to generate
genetically modified mouse models. However, there were significant variations of the targeting efficiency among different genomic loci
using our previously published protocol. In this study, we improved the ZEN technology by delivering Cas9 protein into mouse zygotes
through a series of electroporation. Using this approach, we were able to introduce precise nucleotide substitutions, large segment deletion
and short segment insertion into targeted loci with high efficiency.
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Bacteria and archaea have evolved an adaptive immune system
termed clustered regularly interspaced short palindromic re-
peats (CRISPR)-associated systems to guide the disruption of
the invading viruses or plasmids. Upon optimization, the type
II CRISPR-Cas9 system of Streptococcus pyogenes worked
efficiently in mammalian cells in generating genome modifi-
cations (Cong et al., 2013; Mali et al., 2013; Yang et al., 2015).
Previously, we reported that mice carrying specific point
mutations as well as reporter and conditional alleles could be
generated by delivery of the CRISPR-Cas9 components into
zygotes through microinjection (Wang et al., 2013; Yang et al.,
2013). Using similar strategies, other genetically engineered
animals including rats, monkeys, pigs and dogs were
generated (Hai et al., 2014; Ma et al., 2014; Niu et al., 2014;* Corresponding author. Tel: þ86 10 8261 9213, fax: þ86 10 8261 0049.
E-mail address: wanghaoyi@ioz.ac.cn (H. Wang).
http://dx.doi.org/10.1016/j.jgg.2016.02.004
1673-8527/Copyright  2016, The Authors. Institute of Genetics and Developme
Published by Elsevier Limited and Science Press. This is an open access article underZou et al., 2015). Although this method is highly versatile and
efficient, the delivery procedure depending on microinjection
is technically demanding and labor intensive, therefore
limiting its adaptation in many labs.
To overcome this limitation, we developed the Zygote
Electroporation of Nuclease (ZEN) method (Qin et al., 2015).
We demonstrated that the CRISPR-Cas9 components,
including Cas9 mRNA, sgRNA, and a DNA oligo donor, could
be efficiently delivered into mouse zygotes by electroporation
to generate mice with targeted genetic modifications. ZEN is
easy to learn, high-throughput and less laborious than micro-
injection (Qin et al., 2015). It was also reported by other
groups that the CRISPR-Cas9 components could be efficiently
delivered into the mouse and rat zygotes using different
electroporation setups (Kaneko et al., 2014; Hashimoto and
Takemoto, 2015). However, our previous ZEN protocol had
variations for different target genes, and had a generally lower
efficiency when compared with microinjection (Qin et al.,
2015). At Aicda and Rosa26 loci, non-homologous endntal Biology, Chinese Academy of Sciences, and Genetics Society of China.
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tations occurred at very low efficiency (0% and 17%,
respectively), and we failed to insert LoxP site at the Rosa26
locus using our previous ZEN protocol (data not shown). In
another parallel comparative study between microinjection
and electroporation, ZEN was not able to generate large
segment deletion at Smc1b locus, while the microinjection had
high efficiency (Table S1). To further improve our ZEN pro-
tocol, we selected these genomic loci as targets to introduce
different genetic modifications including precise nucleotide
substitutions, large segment deletion and targeted short
segment insertion. Here, we report the improvement of ZEN
technology, which enables generating mice carrying various
targeted genetic modifications with high efficiency.
RESULTSMultiple times of electroporation improved the mRNA
delivery into mouse zygotesFirst, we optimized our ZEN protocol through using a series
of electroporation instead of just one time of electroporation.
To determine the optimal number of electroporation, we
tested 1, 4, 6, 8 times of electroporation (3 s interval between
electroporation) with the same setting as we previously
published (30 V; 1 ms pulse duration; 2 pulses; 100 ms in-
terval) (Qin et al., 2015), and observed the survival rate of
embryos in two cell and blastocyst stages. While survival rate
was reduced along with increased times of electroporation, 6
times of electroporation still resulted in a reasonable rate of
in vitro development of blastocysts (Fig. S1C). Importantly,
the delivery of GFP mRNA (350 ng/mL) was increased
accordingly when more times of electroporation were applied
(Fig. S1D).
Next, we used Aicda as the target to test whether multiple
times of electroporation will improve the targeting efficiency.
B6D2F2/J embryos derived from natural mating were treated
with acidic Tyrode’s solution for 10 s and then washed
extensively before electroporation. Mouse zygotes were
loaded into 10 mL of Opti-MEM, and then mixed with 10 mL
of CRISPR reagent to achieve final concentration of Cas9
mRNA (600 ng/mL), sgRNA targeting Aicda (300 ng/mL), and
DNA oligo (1000 ng/mL). The DNA oligo comprises sequence
flanking the target region and a few nucleotide changes con-
verting the target sequence (gagaccgatatgg) to the sequence
containing a BamH I site (GGATCC) and an EcoR V site
(GATATC) (Fig. 1A). Zygotes were electroporated for 1, 4, 6
or 8 times, using the same setting as the GFP mRNA elec-
troporation experiment (Fig. S1B). Afterwards the embryos
were transferred into pseudopregnant mice and the pups were
born. Tail tip samples were collected for genotyping. The PCR
products encompassing the target site were characterized by
sequencing and restriction fragment length polymorphism
(RFLP) analysis using EcoR V and BamH I. As shown in
Fig. S2 and Table S2, there was 1 out of 4 mice containing
homology directed repair (HDR) mediated precise nucleotide
substitutions after 6 times of electroporation. But all the othergroups did not generate HDR allele. We also used commercial
Cas9 mRNA for the electroporation with the same setting, and
observed better live birth rate upon multiple times of elec-
troporation. As shown in Table S3, although there was no
success in most of the groups, there were 3 out of 11 mice
containing HDR allele after 8 times of electroporation.Delivery of Cas9 protein through a series of
electroporation dramatically increased the HDR
efficiencyTo further improve the efficiency, we delivered Cas9 protein
together with other components at the same setting as we
delivered Cas9 mRNA. Cas9 protein at 250 ng/mL was used
for all the experimental groups. Embryos were immediately
transferred into pseudopregnant mice after electroporation
and live mice were derived. Some embryos were also
cultured to blastocyst stage and harvested for genotyping
using RFLP and DNA sequencing. Surprisingly, genotyping
of the blastocyst samples indicated that the efficiencies of
generating indel and HDR alleles were both extremely high
after delivery of Cas9 protein through electroporation. Even
one time of electroporation had around 70% HDR efficiency
(Fig. S3 and Table S4). To confirm the precise nucleotide
substitutions, some of the samples were randomly selected
for TOPO cloning and DNA sequencing (Fig. S3C). As
shown in Fig. 1B, the correct HDR was confirmed by the
genotyping results of the live born mice. Using one time of
electroporation, we had 60.00% (6/10) HDR efficiency.
Increasing the times of electroporation to 4 times had the
similarly high efficiency 71.43% (5/7); further increase of the
times of electroporation to 6 times and 8 times yielded
81.33% (5/6) and 100% HDR efficiency (5/5), respectively
(Fig. 1 and Table 1). Importantly, when more times of elec-
troporation were used, more mice containing only the HDR
allele were identified, suggesting a higher efficiency of
generating homozygous HDR animals.Delivery of Cas9 protein through electroporation
achieved high efficiency of large genomic fragment
deletionUsing our previously published protocol (Qin et al., 2015),
ZEN did not work as well as microinjection for 2.2 kb-deletion
at Smc1b locus (Table S1). To test whether delivery of Cas9
protein with a series of electroporation is efficient to generate
large DNA segment deletion, we co-electroporated Cas9 pro-
tein and two sgRNAs targeting sites flanking exons 2e4 of
Smc1b (Fig. 2A). B6D2F2/J embryos were prepared through
IVF (in vitro fertilization) in which GSH (glutathione) was
used to weaken the zona pellucida. The fertilized embryos
were graded, selected and washed. The CRISPR reagent was
added to the embryos to reach final concentration of Cas9
protein (250 ng/mL) and two sgRNAs (300 ng/mL each). After
1, 4 or 6 times of electroporation, the embryos were trans-
ferred and pups were genotyped. As shown in Fig. S4A, 3/9
mice had the 2.2 kb-deletion at the Smc1b locus with one time
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Fig. 1. Delivery of Cas9 protein through electroporation dramatically increased the HDR efficiency.
A: Schematic of the Aicda target sequence and DNA oligo donor. The protospacer sequence is underlined and PAM sequence is colored in green. Oligonucleotides
changed in the DNA oligo donor are in uppercase. The BamH I recognition site is colored in red and the EcoRV recognition site is in blue in the DNA oligo donor.
B: RFLP analysis of 28 mice from group A (A1eA10), B (B1eB7), C (C1eC6) and D (D1eD5). 1, 4, 6 and 8 times of electroporation were used in group A, B, C
and D, respectively. The cleaved bands after EcoRV digestion or BamH I digestion are indicated by black arrow. C: Sequencing traces of PCR products containing
the Aicda target region in the samples labeled in red in B. Clear sequencing traces indicate there is mainly one allele (defined mutation) in the target locus as shown
in B3, C3 and D3, while there are both WT and mutant alleles in A3 mouse. WT, wild type.
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Table 1
CRISPR/Cas9 mediated genome editing of Aicda gene locus through electroporation of Cas9 protein
Time of
electroporation
Number of
embryos
transferred
Number of mice
born
Total mice
analyzed
Live birth rate (%) Percentage of
indela/HDRb (%)
Percentage of
mutantc (%)
1 15 10 10 66.67 50.00/60.00 80.00
4 15 7 7 46.67 71.43/71.43 100.00
6 15 6 6 40.00 50.00/81.33 100.00
8 15 5 5 33.33 40.00/100.00 100.00
a The percentage of mice with indel mutation at the targeting site. b The percentage of mice with precise nucleotide substitutions at the targeting site.
c The percentage of mice with any targeted mutation (indel or HDR, or both).
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20% (1/5) and 33.33% (2/6) deletion efficiency, respectively
(Fig. S4 and Table S5). The correct deletion was confirmed by
Sanger sequencing.
To evaluate the new protocol on inbred strains, we repeated
the experiment using C57BL/6NJ IVF-derived embryos. Two
embryo transfers were performed for each group. Genotyping
results showed that 1 out of 7 mice from 4 times of electro-
poration, and 3 out of 10 mice from 6 times of electroporation
had expected large segment deletion (Fig. 2B and Table 2).
One time of electroporation did not produce large segment
deletion, while it indeed generated indel mutations at both
target sites with high efficiency (Table 2). In addition, multiple
times of electroporation did not influence the live birth rate of
the inbred strain. The above results demonstrated that Cas9
protein delivery through a series of electroporation was effi-
cient in generating large DNA segment deletion in the mouse
genome.Delivery of Cas9 protein through electroporation
achieved high efficiency of targeted small DNA
fragment insertionTo test whether delivery of Cas9 protein with a series of
electroporation is efficient to generate targeted insertion of
small DNA fragments, we prepared IVF embryos from the
C57BL/6NJ strain and did the electroporation with a mixture
of Cas9 protein (250 ng/mL), sgRNA (300 ng/mL) targeting
the Rosa26 locus and a DNA oligo with a LoxP site flanked
by homology sequence (1000 ng/mL) (Fig. 3A). The embryos
were then transferred and live mice were recovered. TIDE
(Tracking of Indels by DEcomposition) analysis of PCR
products encompassing the target site showed that 1, 4, and 6
times of electroporation yielded 4 out of 10 mice, 0 out of 5
mice and 2 out of 3 mice carrying correct LoxP site in
Rosa26 locus, respectively (Table 3). Those samples were
subcloned and independent clones were sequenced. The
sequencing results confirmed the insertion of correct LoxP
site into the Rosa26 locus. Representative images showed the
result of TIDE analysis and Sanger sequencing of one sample
(Fig. 3). These results indicated that the small DNA fragment
could be efficiently inserted into the target region through
electroporation of Cas9 protein in C57BL/6NJ inbred strain
mice.DISCUSSION
Although the ZEN protocol we reported previously worked
efficiently for some target genes, such as Tet2, there were
significant variations among different targets, which limited its
application (Qin et al., 2015). For Aicda, Rosa26, and Smc1b
loci, the old ZEN protocol failed to generate desired model,
while microinjection worked well. By applying a series of
electroporation of Cas9 mRNA, sgRNA and DNA oligo, we
were able to make the precise nucleotide substitutions at Aicda
locus, but the efficiency was still low.
Delivery of Cas9 protein into mammalian primary cells by
electroporation produced genome modification with higher
efficiency than delivery of Cas9 mRNA or plasmids (Liang
et al., 2015; Schumann et al., 2015). It has also been shown
that Cas9 protein delivered to mouse zygotes by microinjec-
tion could induce HDR with high efficiency (Aida et al.,
2015). To further improve the ZEN technology, we per-
formed electroporation using Cas9 protein instead of Cas9
mRNA, and the HDR efficiency was dramatically improved
(Fig. 1). Although delivery of Cas9 protein using one time of
electroporation worked efficiently for generating HDR alleles
(Fig. 1 and Table 3), 6 times of electroporation achieved
higher efficiency in generating homozygous HDR alleles at
Aicda locus, and in producing large DNA segment deletion at
Smc1b locus (Fig. 2). For various genetic modifications (pre-
cise nucleotide changes, targeted short segment insertion, and
large segment deletion) in all three genomic loci, our new
ZEN protocol achieved much higher efficiency than the old
protocol.
The CRISPR-Cas9 system is widely used to generate ani-
mal models (Bassett and Liu, 2014; Liu et al., 2014; Ma et al.,
2014; Niu et al., 2014; Yin et al., 2014; Chapman et al., 2015;
Chen et al., 2015; Ruan et al., 2015; Zou et al., 2015), and
microinjection is still the main method to deliver CRISPR-
Cas9 components into the embryos. In addition to being
technically demanding and low in throughput, microinjection
requires significant investment in equipment and personnel
training. In comparison, our improved ZEN method enables
efficient genome editing in early embryos, while it requires
much less investment and is much easier to learn. It is likely
that the methods reported here could be adapted to facilitate
the generation of genetically modified animal models in other
species with high efficiency and ease.
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Fig. 2. Delivery of Cas9 protein through electroporation achieved high efficiency of genome deletion in an inbred strain.
A: Schematic of the strategy to delete DNA fragment from the Smc1b gene locus. A DNA segment including exon 2, exon 3 and exon 4 was deleted from the
genome. B: Analysis of the sizes of the PCR products through DNA electrophoresis. 1, 4, and 6 times of electroporation were used in groups A (A1eA10), B
(B1eB7) and C (C1eC10), respectively. A small band in B4, C1, C5 and C6, which is around 518 bp long, indicates the successful deletion. The WT band and the
band after deletion were indicated by black arrow. C: Upper panel, the Smc1b target sequence. The two protospace sequences of the two gRNAs are labeled in blue
and PAM sequences are in red. The two arrowheads indicate the position of DNA double strand breaks induced by Cas9. Lower panels, sequencing traces of PCR
products containing the Smc1b target region. The blue line and the red line under the WT sequencing trace indicate the upstream gRNA sequence and the PAM
sequence, respectively. The two blue lines under the sequencing traces of B4, C1, and C5 indicate the remaining upstream and downstream gRNAs. Clear
sequencing traces indicate that mainly one allele was amplified as shown in B4, C1 and C5. WT, wild type.
323W. Wang et al. / Journal of Genetics and Genomics 43 (2016) 319e327MATERIALS AND METHODSPreparation of the reagents for electroporationThe px330 plasmid was used as the template to amplify the
Cas9 coding sequence. T7 promoter sequence was added to
the forward primer. In vitro transcription (IVT) was performed
using mMESSAGE mMACHINE T7 ULTRATranscription kit
(Life Technologies, USA). For sgRNA synthesis, the T7promoter sequence was added to sgRNA sequence through
PCR amplification using 2 universal primers (Table S6) and
one primer with various gRNA sequences (Table S7). The T7-
sgRNA PCR product was purified using Qiagen PCR product
purification kit (Qiagen, Germany) and used as the template
for IVT. The sgRNAs were synthesized using MEGAshort-
script T7 kit (Life Technologies) and purified using MEGA-
clear kit (Life Technologies). Single-stranded DNA oligos
were ordered as Ultramer DNA oligos from Integrated DNA
Table 2
CRISPR/Cas9 mediated large segment deletion of Smc1b through electroporation of Cas9 protein in an inbred strain
Time of
electroporation
Pseudo-ID Number of
embryos transferred
Number of mice
born
Live birth
rate (%)
Percentage of
indela (%) (gRNA1/gRNA2)
Percentage of
2.2 kb-deletionb (%)
1 1 15 6 33.33 80.00/60.00 0
2 15 4
4 3 15 4 23.33 28.57/42.85 14.29
4 15 3
6 5 15 5 33.33 70.00/70.00 30.00
6 15 5
a The percentage of mice with indel mutation at the targeting site of either gRNA1 or gRNA2. b The percentage of mice with the desired 2.2 kb-deletion at
the targeting site.
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listed in Table S8. Commercial Cas9 mRNAwas ordered from
Trilink (L-6125, USA). Cas9 protein was ordered from PNA
Bio (CP01-50, USA) or Thermo Fisher Scientific (B25641,
USA).
To prepare the reagent for electroporation, all the compo-
nents at the required amount were mixed, and lyophilized if
the total volume is higher than 12 mL. If the volume is lower,
TE will be added to achieve 12 mL volume. The mixture was
then centrifuged at 20,000  g for 15 min at 4C. After
centrifugation, 10 mL supernatant was transferred to a newA
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Fig. 3. Delivery of Cas9 protein through electroporation achieved high efficiency
A: Schematic of the Rosa26 target sequence and DNA oligo donor. The protospace
DNA oligonucleotide is underlined. B: A representative image shows the analysis
insertion indicates potential insertion of LoxP site. The result of one of the pups wit
individual clones were sequenced. Sequencing trace from clones A3-1 is shown. Tnuclease free tube. For the preparation of Cas9 RNP (recom-
binant Cas9 protein binding with sgRNA), the solution
including Cas9 protein, sgRNA with or without DNA oligo
were incubated at 37C for 15 min. The samples were then put
on ice and used for electroporation immediately.Zygote isolation, culture and transferAll animal work was approved by the Jackson Laboratory
Animal Care and Use Committee and adhered to the standards
of Guide for the Care and Use of Laboratory Animals set forth159 bp DNA oligo
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Table 3
CRISPR/Cas9 mediated small segment insertion of Rosa26 through electroporation of Cas9 protein in an inbred strain
Time of
electroporation
Pseudo-ID Number of
embryos transferred
Number of
mice born
Total mice
analyzed
Live birth
rate (%)
Percentage of
indela/KIb (%)
Percentage of mutantc (%)
1 1 15 6 6 33.33 60.00/40.00 90.00
2 15 4 4
4 3 15 4 4 20.00 83.33/0 83.33
4 15 2 2
6 5 15 3 3 10.00 66.67/66.67 100
6 15 1bdd 0
a The percentage of mice with indel mutation at the targeting site. b The percentage of mice with LoxP insertion at the targeting site. c The percentage of
mice with any targeted mutation (indel or knock-in (KI), or both). d bd represents born dead.
325W. Wang et al. / Journal of Genetics and Genomics 43 (2016) 319e327by the NIH. When generating embryos via natural mating, the
mouse embryos were isolated and cultured as described pre-
viously (Qin et al., 2015). The IVF was performed following a
standard protocol with some minor changes (Byers et al.,
2006). In brief, Cook RVF medium was used as the fertiliza-
tion medium. Cumulus oocyte masses were pre-incubated in
1.0 mmol/L GSH for 30 min to improve fertilization rate and
weaken the zona pellucida. The embryos were graded for
fertilization and viability and deposited into pre-equilibrated
microdrops of K-RVCL-50 media in COOK MINC bench
top incubator. The PMSG was bought from ProSpec (USA) or
EMD Millipore (Germany). The hCG was bought from
ProSpec (USA) or Sigma-Aldrich (USA).Zygote electroporationElectroporation was performed as described before (Qin et al.,
2015). In brief, zygotes were treated with the acidic Tyrode’s
solution (T1788, Sigma-Aldrich) for 10 s and washed exten-
sively in pre-warmed M2 media. The embryos produced by
IVF were not treated with the acidic Tyrode’s solution. To
weaken the zona pellucida, they were previously treated with
GSH before fertilization in the modified IVF protocol (Byers
et al., 2006). Zygotes were then placed in 10 mL drops of
Opti-MEM media (P/N 31985, Gibco, USA). Ten microlitres
of solution including the Cas9mRNA or protein/sgRNA/donor
DNA oligo was mixed with the Opti-MEM drops containing
embryos and deposited into a 1-mm electroporation cuvette
(P/N 45-0124, Harvard Apparatus, USA). Electroporation was
performed in an ECM830 Square Wave Electroporation Sys-
tem (BTX Harvard Apparatus). The electroporation setting is
the same for all the experiments using 1 ms pulse duration and
two pulses with 100 ms pulse interval at 30V. Following the
electroporation, a pre-warmed 100 mL aliquot of M2 media
was deposited into the cuvette with a sterile plastic pipette to
recover the embryos. The zygotes were removed from the
cuvette and washed in pre-warmed M2 media. Embryos were
then cultured in vitro to blastocysts in a MINC bench top
incubator (COOK; 37C, 5% CO2 and 5% O2/Nitrogen) or
transferred into pseudopregnant female mice (CByB6F1/J).
For the IVF embryos, they were cultured to the two-cell stage
and then transferred.For testing of the survival rate of the embryos after a series
of electroporation, we delivered GFP mRNA at 350 ng/mL
final concentration. Twenty-five embryos from each group
were used. To quantify GFP signal, we randomly drew 4 cir-
cles with the diameter of 10 mm in each embryos. The GFP
intensity was analyzed using Image J. The sum of the values
from four circled areas were used to represent the GFP level in
each embryo, and the average GFP level from each group is
plotted in Fig. S1D.RFLP analysis and Sanger sequencingGenomic DNA from tissue or embryos was extracted using
alkaline lysis as described before (Qin et al., 2015). PCR with
specific primers was performed under the following condi-
tions: 98C for 5 min, 34 cycles (98C for 30 s, 58C (or other
annealing temperature) for 30 s, 68C for 30 s), 68C for
2 min, and hold at 4C. Four microlitres of PCR products were
digested with restriction enzymes and separated on an agarose
gel (1.0%) with GelRed (Biotium, USA). PCR products were
sequenced and cloned into the pCR4 blunt vector from the
Zero Blunt TOPO PCR Cloning Kit (Invitrogen, USA) to
identify the correct single clones. The sequences of the indi-
vidual clones were determined by Sanger sequencing.
For all experiments, the presence of indel allele was
determined by analyzing the sequences of genotyping PCR
products using TIDE software. Mouse containing at least one
allele with small insertion or deletion at target site will be
counted as an indel founder. The percentage of indel is
calculated as the percentage of mice containing indel allele
among all mice analyzed in the same experimental group. For
Aicda locus, the founders containing HDR allele were iden-
tified by RFLP analysis (both EcoR V and BamH I digestion),
followed by sub-cloning and sequencing. For the Rosa26
knock-in (KI) experiments, successful LoxP KI was identified
as containing 34-bp insertion at the target site by TIDE
analysis, followed by sub-cloning and sequencing. The per-
centage of KI is calculated as the percentage of mice con-
taining KI allele among all mice analyzed in the same
experimental group. The percentage of mutant is calculated as
the percentage of mice containing indel, KI, or both types of
mutant alleles among all mice analyzed in the same experi-
mental group.
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